Lymphoma is the 6th most common cancer in France and Spain, with over 11,000 new cases per year in France. The Ambulatory Medical Assistance (AMA) program in Toulouse, France provides lymphoma patients with treatment for 6-8 months followed by a nurse navigator who calls patients twice per week for the first year, every 3 months for the second year, and every 6-12 months for years 3-5. The AMA program is developing a smartphone application to supplement the nurse navigator follow-ups and improve monitoring of patients after cancer treatment, efficacy, adverse drug reactions, and quality of life. The application aims to enhance follow-up for different cancers and chronic diseases using a database for real-

1. Refbio Fase IIRefbio Fase II
Dr. Fabien DESPAS, Pharmacologist
UPS Toulouse
MCU-PH, PharmD, PhD
Ambulatory Medical Assistance in
Cancer : Keeping in touch with
Patients

2. Refbio Fase IIRefbio Fase II
Epidemiology of lymphoma
– 6th cancer in frequency
• France: 11 000 new diagnosis/year
• Spain: 6 130 new diagnosis/year
– 9th cancer in mortality
– Relative survival :
• At 5 years: 85% in men and 92% in women
Ambulatory Medical Assistance (AMA)
in Lymphoma
Diagnosis
Treatment (6-8 months)
Efficacy &
Adverse Drugs Reactions (ADR)
After Cancer
Quality of life
Delayed ADR
Course of the management
Difficulties in respect of doses and
in the management of ADRs

3. Refbio Fase IIRefbio Fase II
Nurse navigator
- 2 calls per week
AMA
Ambulatory Medical Assistance (AMA)
in Lymphoma
Since 2006 in Toulouse : AMA follow-up
Nurse navigator
-1st year : every 3 months
-2nd year : every 6 months
-3 to 5 years : every 12 months
General Practitioner
-Every 12 months
Treatment (6-8 months)
Efficacy &
Adverse Drugs Reactions (ADR)
After Cancer
Quality of life
Delayed ADR

4. Refbio Fase IIRefbio Fase II
Nurse navigator
- 2 calls per week
AMA
Ambulatory Medical Assistance (AMA)
in Lymphoma
The PROJECT : Smartphone application
Nurse navigator
-1st year : every 3 months
-2nd year : every 6 months
-3 to 5 years : every 12 months
General Practitioner
-Every 12 months
Treatment (6-8 months) After Cancer

5. Refbio Fase IIRefbio Fase II
• Follow-up based on combination of nurse
navigator and Smartphone application
– Different types of cancer
– Different types of chronic disease
– Follow-up of news drugs
– Database available for real life research
Keeping in touch with Patients

6. Thank you for
your attention
www.refbio.eu
Fabien DESPAS
fabien.despas@univ-tlse3.fr
Programme financé par le FEDER

7. Refbio Fase IIRefbio Fase II